Assessing the mechanisms of cholesteryl ester transfer protein inhibitors

Cholesteryl ester transfer protein (CETP) inhibitors are a new class of therapeutics for dyslipidemia that simultaneously improve two major cardiovascular disease (CVD) risk factors: elevated low-density lipoprotein (LDL) cholesterol and decreased high-density lipoprotein (HDL) cholesterol. However,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biochim Biophys Acta Mol Cell Biol Lipids
Main Authors: Zhang, Meng, Lei, Dongsheng, Peng, Bo, Yang, Mickey, Zhang, Lei, Charles, M. Art, Rye, Kerry-Anne, Krauss, Ronald M., Johns, Douglas G., Ren, Gang
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6239860/
https://ncbi.nlm.nih.gov/pubmed/28911944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbalip.2017.09.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados